These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6795756

  • 21. 9,11-epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets.
    Fitzpatrick FA, Bundy GL, Gorman RR, Honohan T.
    Nature; 1978 Oct 26; 275(5682):764-6. PubMed ID: 703845
    [No Abstract] [Full Text] [Related]

  • 22. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
    Moncada S.
    Mater Med Pol; 1980 Oct 26; 12(3):207-12. PubMed ID: 7019591
    [No Abstract] [Full Text] [Related]

  • 23. Thromboxane and prostacyclin in disease: a review.
    Halushka PV, Dollery CT, MacDermot J.
    Q J Med; 1983 Oct 26; 52(208):461-70. PubMed ID: 6361838
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. U-46619-induced ischaemic electrocardiographic changes in rats: preventive effects of prostacyclin and nitroglycerin.
    Yamamoto T, Kikuta C, Hosoki K.
    J Pharm Pharmacol; 1994 Jul 26; 46(7):558-62. PubMed ID: 7996382
    [Abstract] [Full Text] [Related]

  • 30. The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.
    Bunting S, Moncada S, Vane JR.
    Br Med Bull; 1983 Jul 26; 39(3):271-6. PubMed ID: 6354352
    [No Abstract] [Full Text] [Related]

  • 31. Mechanism of nitroglycerin-induced coronary dilatation: lack of relation to intracoronary thromboxane concentrations.
    Rehr RB, Jackson JA, Winniford MD, Campbell WB, Hillis LD.
    Am J Cardiol; 1984 Nov 01; 54(8):971-4. PubMed ID: 6437206
    [Abstract] [Full Text] [Related]

  • 32. Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
    Moncada S, Vane JR.
    Drug Ther; 1982 Nov 01; ():37-65. PubMed ID: 7049651
    [No Abstract] [Full Text] [Related]

  • 33. Metabolic fate of thromboxane A2 and prostacyclin.
    Roberts LJ, Brash AR, Oates JA.
    Adv Prostaglandin Thromboxane Leukot Res; 1982 Nov 01; 10():211-25. PubMed ID: 6216783
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of nitroglycerin on human vascular prostacyclin and thromboxane A2 generation.
    Mehta J, Mehta P, Ostrowski N.
    J Lab Clin Med; 1983 Jul 01; 102(1):116-25. PubMed ID: 6406630
    [Abstract] [Full Text] [Related]

  • 38. Selective inhibition of thromboxane-related platelet function by low-dose aspirin in patients after myocardial infarction.
    De Caterina R, Giannessi D, Bernini W, Gazzetti P, Michelassi C, L'Abbate A, Donato L, Patrignani P, Filabozzi P, Patrono C.
    Am J Cardiol; 1985 Feb 15; 55(5):589-90. PubMed ID: 3969908
    [No Abstract] [Full Text] [Related]

  • 39. [Pharmacological action on the thromboxane and prostacyclin balance in the body].
    Lakin KM, Makarov VA, Novikova NV, Tret'iak VM, Rukazenkov IuE.
    Farmakol Toksikol; 1984 Feb 15; 47(2):67-79. PubMed ID: 6425078
    [No Abstract] [Full Text] [Related]

  • 40. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H, Stegmeier K.
    Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.